Dr. Lal PathLabs Limited IPO Message Board (Page 16)

in both alkem and dr lal
to get allotment for sure as retail investor which lot is best
means dr lal me kis lot ke liye (20,40 .....180....360) or alkem ke liye koun sa lot(14,28,42.....182).
please guide further.

Apply for 1lot I.e 20 / 14 shares . Since in new IPO allotment system all applicants irrespective of quantity applied will be allotted 20/ 14 shares . Left ove after after this will be given proportionately to higher quantity applicants.

Dr.Lal GMP 120-125 (active trading with big volumes)

In Bhavnagar Kostak for Alkem and Dr. Lal Path labs is trading @ 2600 For consolidated Deal.

For Alchem individually it is 1600

For Dr. Lal path lab individually it is 900.

Seems to be a good deal.

2600 In the pocket even if you don''''t get allotment.


And need to repay only if the gain on sale is beyond 1600 per lot of 14 eq. shares, ie. listing above Rs. 1165/- on the opening day for Alkem and

And need to repay only if the gain on sale is beyond 900 per lot of 20 eq. shares, ie. listing above Rs. 580/- on the opening day for Dr. lal Path Labs

And in case of No Allotment.....

2600 is definitely in your pocket.


So Enjoy The Deals post Diwali.

Good , Thanks for Info, i am from Rajkot

Hope GST bill will pass in winter season & both ipo will list more than GMP rate.

Anu Raghunathan , CONTRIBUTOR
I write about Indian entrepreneurs.
FOLLOW ON FORBES
Opinions expressed by Forbes Contributors are their own.
Dr. Devi Prasad Shetty – a pioneer of affordable healthcare in India as well as founder and chairman of Narayana Hrudayalaya Limited in Bangalore – has filed a draft red herring prospectus for an initial public offering with the Securities and Exchange Board of India. The company is looking to raise more than $100 million.

The 62-year-old cardiac surgeon, who is often seen in a blue surgical outfit, used to be Nobel laureate Mother Teresa’s personal physician. Dr. Shetty’s NH hospitals perform thousands of heart surgeries every year and work on reducing costs through sheer scale centralized purchases and innovations in intensive care. He believes that a no-frills low-cost approach will make healthcare more accessible to the common man.

Here are the key highlights of the prospectus that was filed last month.


Dr. Devi Prasad Shetty – advocate of no-frills, low-cost healthcare, files for an IPO for his company – Narayana Hrudayalaya Limited (Photo credit: Manjunath Kiran/AFP/Getty Images)

What is NH’s reach?

It has 5,600 beds and the network includes 23 hospitals, 8 heart centers and 25 primary care centers spanning 32 cities, towns and villages in India.


What is the geographical spread?

NH has a strong presence in the southern Indian state of Karnataka as well as in eastern India. It has a growing presence in western and central India. It has hospitals in Bangalore, Mysore, Hyderabad, Kolkata and Ahmedabad – among other cities.It’s looking to up a pediatric hospital in Mumbai and a multispecialty hospital in Lucknow, Uttar Pradesh.

Who are the people behind NH?

NH was founded in 2000 by Dr. Devi Prasad Shetty. He has more than three decades of experience –as a cardiac surgeon – both in the UK and in India. He is a vocal advocate for affordable healthcare. He helped design the Yeshasvini scheme – a micro insurance program in Karnataka.

Recommended by Forbes
MOST POPULAR Photos: The Richest Person In Every State
TRENDING ON LINKEDIN The Surprising Math In Mark Zuckerberg''s $45 Billion Facebook Donation

What is the history of the company?

It was first started in Bangalore with 225 beds. It now has 5,600 beds with the aspiration to get to 30,000 beds by 2020

What is the employee count?

As of July 31, NH had 11,478 employees and students – including 818 doctors and 5,438 nurses. It also has 1,660 doctors who are consultants or visiting consultants.

What are NH’s key financials?

It had revenues of $219 million for fiscal 2015 and profit after tax of $ 2 million. For the four fiscal years ended March 31, 2015, its revenues grew at a compounded rate of 30 percent.

Who are the investors behind NH?

Dr. Shetty and his wife Shakuntala Shetty own 68.62 percent of the company. JPMorgan owns 11 percent and UK investment group CDC has about 6 percent. Biocon founder Kiran Mazumdar Shaw owns 2.35 percent.

Who are NH’s key competitors?

Its biggest competitors are Chennai’s Apollo Hospitals Limited which has about four times its revenues and Delhi’s Fortis Healthcare which is about three times bigger than NH in revenue terms.

How many patients are treated in NH hospitals on an annual basis?

In the fiscal year 2015, it catered to nearly 2 million patients. NH performed 51,456 cardiology procedures, 14,036 cardiac surgeries, and 184,443 dialysis procedures.

Narayana Gmp 38-42
Kostak 500

Narayana Hrudalaya ipo
15th-17th December 2015
Price band 305-317
Lot 45
Retail Discount Rs 7

Anchor Book 14th December 2015

Edelweiss

Your Information is incorrect.

Narayana Hrudayalaya’s IPO Opens on 17th December & Closes on 21st December
Offer price Band may Rs. 240 to 250 (Lot Size: 60 Shares)

Koi batto ipo bharna ya nahi?

It will list below 500.
Enjoy ipo
I am strictly avoiding this hope retailers will also follow my advice and not apply otherwise they will loose

Dr. Lal current GMP is 125 ... which implies the grey market is expecting the listing @675ish.

You obviously have a rather poor opinion of this stock ... so have you actioned your view ?
Are you recommending we should go naked short in grey ?

The counter has turned weak ... GMP dropped:

Dr.Lal GMP 100-102 (down tick with big volumes)

ALKEM KOSTAK PLZ :
DR.LAL PATHALABS KOSTAK :

BHEESS K AAGEY BEEN NA BAJIYO


SAB KO LOOOOOT LEGA
ISKO MAT LAGAO RETAILERS
TUMHARE PAISE GAYE
YEH 300 PAI LIST HOGAI

BHAI LOG ISIS KO MANO
YEH LOOOOTEGAI BACHA LOI APNE PAISA
PAISA KHANAI A GAYA CHHOOOOOORR
HAMRAYE PAISAAE KHA LEGA BAHUT LOOOOTENGE
BACHA LOI APNE PAISAI SAAARRE CHALE JAYENGE

Before forming such strong opinions ... Have you even read the DRHP or the RHP?
May you offer some rational for such harsh comments about the IPO?
or is that just your gut feeling based on your sixth sense ??

Avoid

Jisko bi laga hai ki ye ipo loot lega over priced hai to aaap apnapni app sell karke safe ho jaoo naa.

10700rs laglaga kar 10din mai 1000 rs mil jyega isse Acha kya return chyee

Gray market priemum is strong 110-120.

Gmp crashed to Rs. 45 only seller
Kostak 400 seller.

witch ipo name??

Avoid this ipo
Surely list at discount
It will trade below 500
Gmp Discount 35

It will looooooooot u
It will kooooooooot u

Saab ko rolaega Dr lal

But gmp 170-175 by smart investment pl reply

I dont know the latest but according to zee business it was 105 yesterday.

Both IPOs Lal Pathlabs and Alkem lab are very good. Blindly we can apply these IPOs for good returns.

GMP 130
LAL hi LAL
MAAL LAO !!!!

Septa Ji,

Are you planning to apply both Dr. Lal pathlabs and Alkem laboratories? Please suggest.

i am going to apply Alkem for sure however LAL i am avoiding given it steep valuation.... it could list at premium

Miss pinkyjain what is the true gmp of Dr.Lal pathlabs?once its in discount and the next moment its 90 rs premium. What is true